FDA targets early September for approving Pfizer's Covid-19 vaccine

According to one senior administration official they claim that they are working hard to make it happen as soon as possible.A spokesperson for FDA declined to give a timetable but said that the rapid rise in Covid-19 infection caused by the Delta variant prompted the agency to accelerate its work.We have acknowledged the urgent nature of the current pandemic and taken an all-hands-on deck approach," the spokesperson stated. This prioritization included the redirection of additional resources and personnel to the review.The White House has downplayed any potential impact of the FDA approval on its vaccination campaign and stressed instead the overwhelming evidence that vaccines are safe and effective. It has resisted any involvement in the FDA's review of the vaccines, fearing that it might put pressure on the agency.Two people familiar with the matter said that the lengthy process in private has disappointed some administration officials. They believe there is no reason for such a long wait. To undercut vaccine skeptics, who have been arguing against the shot until it is officially approved by the FDA, the administration wants to use the full approval.According to Kaiser Family Foundation polling, around 30 percent of people who are not vaccinated would prefer to receive a fully approved vaccine to an emergency shot. However, pollsters found that most respondents didn't know the difference and believed the vaccines were already approved. This suggests that this benchmark may be indicative of broader concerns.Pfizer applied for full approval in May and Moderna followed in June. FDA reviews can take several months.The FDA's September schedule for approval was first reported by the New York Times.Only emergency authorizations are granted in the event of a public health emergency. They expire when an emergency declaration is made. These authorizations signify that FDA believes that there may be a benefit to a vaccine or therapy, while approval signifies that the agency has deemed the product safe and effective.Recent weeks saw vaccination rates rise as fears about the more deadly Delta variant spread. This led to hospitalization surges and renewed mask mandates across the country. This week, the country met President Joe Biden's target of 70% adult vaccination. It was just one month short of his original goal and only days after the president stated that federal workers must be vaccinated.But vaccine resisters represent tens to millions of Americans, many of whom live in states like the Midwest and Southern States where coronavirus surges have put a strain on hospitals and public health resources. Some governors oppose other measures, such as the reinstituting of mask mandates. This angers the president.Governors, I ask you to help. Biden stated Tuesday that if you aren't willing to help, then get out of the way for people who want to do the right things.